211: The significance of palifermin (Kepivance®) in reduction of oral mucositis (OM) incidence and acute graft versus host disease in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT)
2007 ◽
Vol 13
(2)
◽
pp. 77-78
◽
2012 ◽
Vol 18
(11)
◽
pp. 1734-1744
◽
2015 ◽
Vol 21
(2)
◽
pp. S369
2018 ◽
Vol 53
(4)
◽
pp. 377-382
◽
2009 ◽
Vol 15
(2)
◽
pp. 20-21
◽
2013 ◽
Vol 98
(1)
◽
pp. 96-101
◽
2019 ◽
Vol 20
(4)
◽
pp. 1014-1027
◽
2019 ◽
Vol 41
(5)
◽
pp. 620-627
◽